GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Other Operating Expense

Telcon RF Pharmaceutical (XKRX:200230) Other Operating Expense : ₩8,057 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Telcon RF Pharmaceutical Other Operating Expense?

Telcon RF Pharmaceutical's Other Operating Expense for the three months ended in Mar. 2025 was ₩2,121 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩8,057 Mil.

Telcon RF Pharmaceutical's quarterly Other Operating Expense increased from Sep. 2024 (₩1,690 Mil) to Dec. 2024 (₩2,421 Mil) but then declined from Dec. 2024 (₩2,421 Mil) to Mar. 2025 (₩2,121 Mil).

Telcon RF Pharmaceutical's annual Other Operating Expense declined from Dec. 2022 (₩7,321 Mil) to Dec. 2023 (₩6,621 Mil) but then increased from Dec. 2023 (₩6,621 Mil) to Dec. 2024 (₩7,211 Mil).


Telcon RF Pharmaceutical Other Operating Expense Historical Data

The historical data trend for Telcon RF Pharmaceutical's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telcon RF Pharmaceutical Other Operating Expense Chart

Telcon RF Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,337.97 7,012.44 7,321.28 6,621.36 7,210.69

Telcon RF Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,735.43 1,825.56 1,689.95 2,421.15 2,120.63

Telcon RF Pharmaceutical Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,057 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telcon RF Pharmaceutical Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Telcon RF Pharmaceutical's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Telcon RF Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
684, Dongtangiheung-ro, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 17102
Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It develops connectors for input and output ports, board-to-board, cable assembly, and board-to-mount used in wireless communication equipment. The company also supplies RF coaxial connectors. The company operates in the RF Division and Pharmaceuticals & Biotechnology segments. The majority of its revenue is generated from Pharmaceuticals & Biotechnology, which produces and sells liquids, tablets, pills, capsules, etc.

Telcon RF Pharmaceutical Headlines

No Headlines